Latest Debt Refinancing News

Charter Hall Long WALE REIT (ASX:CLW) announced a quarterly distribution of AUD 0.06375 per security for Q4 FY26, payable in August, alongside a Dividend Reinvestment Plan offering a 1% discount on reinvestment price.

PLS Group has greenlit a substantial pre-FID spend to keep its P2000 lithium expansion on track, aiming for a final investment decision by late 2026 and first ore by mid-2029.

Australian Agricultural Company (ASX:AAC) defied North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.

Growthpoint Properties Australia sustains strong office leasing momentum in FY26 with 54,721 sqm executed and reaffirmed financial guidance, supported by active capital management and leadership appointments.

Charter Hall Long WALE REIT (ASX:CLW) has completed a $2 billion secured debt refinancing, extending its debt maturity profile by 1.6 years and reducing credit margins by 20 basis points, while reaffirming FY26 earnings and distribution guidance.

Ryman Healthcare has opened a NZ$100 million fixed rate bond offer maturing in 2032, featuring an exchange mechanism for existing bondholders and a minimum interest rate of 5.60%. The offer targets institutional and retail investors and aims to refinance debt and diversify funding.

Ryman Healthcare has launched a NZ$100 million fixed rate bond offer maturing in 2032, aiming to refinance existing debt and diversify its funding sources. The offer includes an exchange mechanism for existing bondholders, with trading in current bonds to be suspended during the transition.

Almonty Industries has announced a $700 million convertible senior notes offering due 2031, aiming to refinance existing debt and fund corporate initiatives amid rising tungsten demand.

Chrysos Corporation has refinanced its debt with a $200 million syndicated facility, enhancing financial flexibility to accelerate manufacturing and deployment of its PhotonAssay technology worldwide.

Promisia Healthcare reported a 58% jump in underlying EBITDAF to $6.6 million for FY26, driven by improved occupancy and operational upgrades. The company introduced a dividend policy tied to operating free cash flow, signalling confidence in sustained cash generation.

Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.

Cryosite Limited delivered a robust 22% revenue increase and 28% EBITDA growth for the ten months to April 2026, powered by expanding clinical trial activity and infrastructure upgrades.